National ICMR Distances Itself From BHU's 'Poorly Designed' Study On Covaxin Side Effects BY Asmita Ravi Shankar
National After Covishield, Now Covaxin Hits Headlines Over 'Health Issues' In 30% Of Those Jabbed BY Outlook News Desk
National Bharat Biotech Highlights Covaxin's 'Safety First' Feature Amid AstraZeneca's Covishield Row Over Side Effects BY Outlook News Desk
National Serum Institute Seeks Inclusion Of Covovax On CoWIN As Heterologous Booster Dose For Adults BY PTI
National Covovax Booster Dose For Covid-19, Its Efficacy Rate And How Does It Work? All You Need To Know BY Outlook News Desk
National Government Not Liable For Vaccine-Related Deaths: Centre To Supreme Court BY Outlook News Desk
National Immunity From Natural Covid Infection, Vaccines Not Absolute: Minister of State for Health BY Outlook News Desk
National NTAGI Panel Recommends Use Of Covid-19 Vaccines Corbevax, Covaxin For Children Aged 5-12 Years BY Outlook News Desk
National Covaxin Safe And Highly Effective In Children Between 2-18 Years Of Age, Shows Study BY Outlook News Desk
National Covaxin Booster Dose Enhances Vaccine Effectiveness Against Delta, Omicron Variants, Says ICMR Study BY Outlook News Desk
National Biological E Seeks EUA For Corbevax As Booster In Adults Vaccinated With Covishield, Covaxin BY Outlook News Desk
National Bharat Biotech Must Address WHO's Covaxin Suspension To Avoid EUL Cancellation, Says MEA BY Outlook News Desk
National DCGI Grants EUA To Corbevax For Those Aged 5-12, Covaxin For 6-12 Age Group BY Outlook News Desk
National Covid Vaccine Covaxin Cleared For 6-12 Age Group By Drugs Regulator DCGI: Reports BY Outlook News Desk
National SII To Give Free Covishield Vials To Pvt Vaccination Centres To Compensate For Price Difference BY Outlook News Desk
National Covaxin Booster Enhances Antibody Response Against COVID-19 Variants Including Omicron: Study BY Outlook News Desk
